Skip to main content

Vaccines Against Malaria (1996) / Chapter Skim
Currently Skimming:

5 Solutions for Science
Pages 17-18

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 17...
... A single vaccine could conceivably meet both requirements, but participants acknowledged that cost considerations, as well as immunologic and epidemiologic differences in vaccine requirements, justify setting two separate goals for vaccine development. A number of avenues need to be explored.
Read the entire page →
From page 18...
... While no one can predict what a final successful malaria vaccine will be, workshop participants generally agreed that the elements for scientific success are moving into place. What is most needed now is a focused, systematic, and multisectoral approach to vaccine development that, as a first step, identifies the scientific hurdles remaining and the funds that will be required to overcome them.
Read the entire page →

Key Terms

  • malaria vaccines
  • vaccine tested
  • vaccine effort
  • conjugate vaccine
  • final successful

  • vaccine development
  • premise holds
  • optimally induce
  • protective antibodies
  • vaccinia tested

  • synthetic peptide
  • recombinant vaccinia
  • protein vaccine
  • produced recombinant
  • peptide carrier

  • carrier conjugate
  • scientific success
  • recombinant protein
  • multistage microorganism
  • separate vaccines

  • successful malaria
  • monophosphoryl lipid
  • adjuvant formulations
  • multivalent recombinant
  • workshop participants

  • malaria antigens
  • single vaccine
  • vaccine requirements
  • defined protective
  • scientific hurdles


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.